Why does brain metabolism not favor burning of fatty acids to provide energy-Reflections on disadvantages of the use of free fatty acids as fuel for brain

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 10, 2013, Pages 1493-1499

  Schönfeld, Peter ^a   Reiser, Georg ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

ATP generation; fatty acid; mitochondria; neural cells; oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; OXYGEN; SUPEROXIDE;

BRAIN METABOLISM; BRAIN MITOCHONDRION; ENERGY; FATTY ACID OXIDATION; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HYPOXIA; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; HUMANS; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN;

EID: 84885023188     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.128     Document Type: Review

References (82)

1. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001; 21: 1133-1145. (Pubitemid 32947479)
2. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic Neurochemistry. Raven Press: New York, 1994, pp 645-680.
3. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull 2008; 76: 329-343.
4. Bélanger M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 2011; 14: 724-738.
5. Shetty PK, Galeffi F, Turner DA. Cellular links between neuronal activity and energy homeostasis. Front Pharmacol 2012; 3: 43.
6. Hu Y, Wilson GS. Rapid changes in local extracellular rat brain glucose observed with an in vivo glucose sensor. J Neurochem 1997; 68: 1745-1752. (Pubitemid 27133086)
7. Dienel GA. Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab 2012; 32: 1107-1138.
8. Pellerin L, Magistretti PJ. Sweet sixteen for ANLS. J Cereb Blood Flow Metab 2012; 32: 1152-1166.
9. Bolañ os JP, Almeida A, Moncada S. Glycolysis: a bioenergetic or a survival pathway? Trends Biochem Sci 2010; 35: 145-149.
10. Hashimoto T, Hussien R, Cho HS, Kaufer D, Brooks GA. Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles. PLoS One 2008; 3: e2915.
11. Obel LF, Mü ller MS, Walls AB, Sickmann HM, Bak LK, Waagepetersen HS et al. Brain glycogen-new perspectives on its metabolic function and regulation at the subcellular level. Front Neuroenergetics 2012; 4: 3.
12. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 2005; 28: 109-121. (Pubitemid 40723878)
13. Cahill Jr. GF. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26: 1-22.
14. Spitzer JJ. CNS and fatty acid metabolism. Physiologist 1973; 16: 55-68.
15. Ebert D, Haller RG, Walton ME. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci 2003; 23: 5928-5935. (Pubitemid 36807872)
16. Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 1992; 70: Suppl S118-S129. (Pubitemid 23091615)
17. Mitchell RW, Hatch GM. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins Leukot Essent Fatty Acids 2011; 85: 293-302.
18. Davletov B, Montecucco C. Lipid function at synapses. Curr Opin Neurobiol 2010; 20: 543-549.
19. Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Prog Lipid Res 2010; 49: 61-75.
20. Kimura S, Amemiya F. Brain and liver pathology in a patient with carnitine deficiency. Brain Dev 1990; 12: 436-439. (Pubitemid 20340535)
21. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991; 56: 1376-1386. (Pubitemid 21902060)
22. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res 1987; 18: 551-561. (Pubitemid 18007554)
23. Escartin C, Pierre K, Colin A, Brouillet E, Delzescaux T, Guillermier M et al. Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults. J Neurosci 2007; 27: 7094-7104. (Pubitemid 47037552)
24. Oyanagi E, Yano H, Kato Y, Fujita H, Utsumi K, Sasaki J. L-Carnitine suppresses oleic acid-induced membrane permeability transition of mitochondria. Cell Biochem Funct 2008; 26: 778-786.
25. Sultan A, Sokolove PM. Free fatty acid effects on mitochondrial permeability: an overview. Arch Biochem Biophys 2001; 386: 52-61. (Pubitemid 32980176)
26. Benard G, Faustin B, Passerieux E, Galinier A, Rocher C, Bellance N et al. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 2006; 291: C1172-C1182. (Pubitemid 44878587)
27. Hamilton JA, Brunaldi K. A model for fatty acid transport into the brain. J Mol Neurosci 2007; 33: 12-17. (Pubitemid 47574951)
28. Hamilton JA. Fatty acid transport: difficult or easy? J Lipid Res 1998; 39: 467-481. (Pubitemid 28158391)
29. Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int 2009; 55: 476-482.
30. Smith QR, Nagura H. Fatty acid uptake and incorporation in brain: studies with the perfusion model. J Mol Neurosci 2001; 16: 167-172. (Pubitemid 32664776)
31. Spector R. Fatty acid transport through the blood-brain barrier. J Neurochem 1988; 50: 639-643. (Pubitemid 18042340)
32. Williams WM, Chang MC, Hayakawa T, Grange E, Rapoport SI. In vivo incorporation from plasma of radiolabeled palmitate and arachidonate into rat brain microvessels. Microvasc Res 1997; 53: 163-166. (Pubitemid 27202433)
33. Bonen A, Chabowski A, Luiken JJ, Glatz JF. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 2007; 22: 15-29.
34. Kampf JP, Kleinfeld AM. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda) 2007; 22: 7-14.
35. Seelig A. The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J Mol Neurosci 2007; 33: 32-41. (Pubitemid 47574956)
36. Mitchell RW, On NH, Del Bigio MR, Miller DW, Hatch GM. Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J Neurochem 2011; 117: 735-746.
37. Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J. Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis 2012; 11: 117.
38. Fraser PA. The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med 2011; 51: 967-977.
39. Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE. Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol 2009; 297: R655-R664.
40. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 2003; 9: 756-761. (Pubitemid 36749226)
41. Yang SY, He XY, Schulz H. Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase. J Biol Chem 1987; 262: 13027-13032.
42. Bird MI, Munday LA, Saggerson ED, Clark JB. Carnitine acyltransferase activities in rat brain mitochondria. Bimodal distribution, kinetic constants, regulation by malonyl-CoA and developmental pattern. Biochem J 1985; 226: 323-330. (Pubitemid 15127939)
43. Ellis JM, Wong GW, Wolfgang MJ. Acyl coenzyme A thioesterase 7 regulates neuronal fatty acid metabolism to prevent neurotoxicity. Mol Cell Biol 2013; 33: 1869-1882.
44. Stewart VC, Land JM, Clark JB, Heales SJ. Comparison of mitochondrial respiratory chain enzyme activities in rodent astrocytes and neurones and a human astrocytoma cell line. Neurosci Lett 1998; 247: 201-203. (Pubitemid 28240132)
45. Almeida A, Brooks KJ, Sammut I, Keelan J, Davey GP, Clark JB et al. Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain. Dev Neurosci 1995; 17: 212-218.
46. Almeida A, Almeida J, Bolanos JP, Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci USA 2001; 98: 15294-15299. (Pubitemid 34014008)
47. Barreto GE, Gonzalez J, Torres Y, Morales L. Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res 2011; 71: 107-113.
48. Di Paola M, Lorusso M. Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition. Biochim Biophys Acta 2006; 1757: 1330-1337. (Pubitemid 44442109)
49. Wojtczak L, Schö nfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1993; 1183: 41-57. (Pubitemid 23322954)
50. Kahlert S, Schö nfeld P, Reiser G. The Refsum disease marker phytanic acid, a branched chain fatty acid, affects Ca2\+ homeostasis and mitochondria, and reduces cell viability in rat hippocampal astrocytes. Neurobiol Dis 2005; 18: 110-118. (Pubitemid 40092901)
51. Schö nfeld P, Schluter T, Fischer KD, Reiser G. Non-esterified polyunsaturated fatty acids distinctly modulate the mitochondrial and cellular ROS production in normoxia and hypoxia. J Neurochem 2011; 118: 69-78.
52. Hein S, Schö nfeld P, Kahlert S, Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet 2008; 17: 1750-1761. (Pubitemid 351791501)
53. Aubourg P, Dubois-Dalcq M. X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia? Glia 2000; 29: 186-190. (Pubitemid 30044514)
54. Klenk E, Kahike W. [ON THE PRESENCE OF 3,7,11,15-TETRAMETHYLHEXADECANOIC ACID (PHYTANIC ACID) IN THE CHOLESTEROL ESTERS AND OTHER LIPOID FRACTIONS OF THE ORGANS IN A CASE OF A DISEASE OF UNKNOWN ORIGIN (POSSIBLY HEREDOPATHIA ATACTICA POLYNEURITIFORMIS, REFSUM'S SYNDROME)]. Hoppe-Seyler's Zeitschrift fur physiologische Chemie 1963; 333: 133-139.
55. Schö nfeld P, Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic Biol Med 2008; 45: 231-241.
56. Facundo HT, Carreira RS, de Paula JG, Santos CC, Ferranti R, Laurindo FR et al. Ischemic preconditioning requires increases in reactive oxygen release independent of mitochondrial K\+ channel activity. Free Radic Biol Med 2006; 40: 469-479. (Pubitemid 43139682)
57. Mironov SL, Hartelt N, Ivannikov MV. Mitochondrial KATP channels in respiratory neurons and their role in the hypoxic facilitation of rhythmic activity. Brain Res 2005; 1033: 20-27. (Pubitemid 40175101)
58. Carreira RS, Miyamoto S, Di Mascio P, Goncalves LM, Monteiro P, Providencia LA et al. Ischemic preconditioning enhances fatty acid-dependent mitochondrial uncoupling. J Bioenerg Biomembr 2007; 39: 313-320. (Pubitemid 350030797)
59. Busanello EN, Zanatta A, Tonin AM, Viegas CM, Vargas CR, Leipnitz G et al. Marked inhibition of Na\+, K\+-ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease. J Bioenerg Biomembr 2013; 45: 137-144.
60. Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab 1989; 9: 2-19. (Pubitemid 19053430)
61. Siesjö BK. Brain Energy Metabolism. Wiley: New York, 1978.
62. Erecinska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001; 128: 263-276. (Pubitemid 33051004)
63. Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab 2012; 15: 805-812.
64. Waldbaum S, Patel M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 2010; 88: 23-45.
65. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
66. Rodrigues JV, Gomes CM. Mechanism of superoxide and hydrogen peroxide generation by human electron-transfer flavoprotein and pathological variants. Free Radic Biol Med 2012; 53: 12-19.
67. Schö nfeld P, Wojtczak L. Brown adipose tissue mitochondria oxidizing fatty acids generate high levels of reactive oxygen species irrespective of the uncoupling protein-1 activity state. Biochim Biophys Acta 2012; 1817: 410-418.
68. Seifert EL, Estey C, Xuan JY, Harper ME. Electron transport chain-dependent and-independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation. J Biol Chem 2010; 285: 5748-5758.
69. Schö nfeld P, Wieckowski MR, Lebiedzinska M, Wojtczak L. Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transferassociated production of reactive oxygen species. Biochim Biophys Acta 2010; 1797: 929-938.
70. Dumont M, Beal MF. Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 2011; 51: 1014-1026.
71. Sorce S, Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 2009; 11: 2481-2504.
72. Baarine M, Andreoletti P, Athias A, Nury T, Zarrouk A, Ragot K et al. Evidence of oxidative stress in very long chain fatty acid-treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins. Neurosci 2012; 213: 1-18.
73. Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P et al. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta 2012; 1822: 1475-1488.
74. Speijer D. Oxygen radicals shaping evolution: why fatty acid catabolism leads to peroxisomes while neurons do without it: FADH2/NADH flux ratios determining mitochondrial radical formation were crucial for the eukaryotic invention of peroxisomes and catabolic tissue differentiation. BioEssays 2011; 33: 88-94.
75. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988; 241: 462-464.
76. Sappey-Marinier D, Calabrese G, Fein G, Hugg JW, Biggins C, Weiner MW. Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992; 12: 584-592.
77. Hochachka PW. Muscles As Molecular And Metabolic Machines. CRC Press: Boca Raton, 1994.
78. Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res 2002; 41: 197-239.
79. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010; 90: 207-258.
80. Kienesberger PC, Pulinilkunnil T, Nagendran J, Dyck JR. Myocardial triacylglycerol metabolism. J Mol Cell Cardiol 2013; 55: 101-110.
81. Greenhaff PL, Hultman E, Harris RC. Principles of Exercise Biochemistry. In: Poortmans JR (ed) Medicine and Sport Science. Karger: Basel, 2004, pp 108-151.
82. Azarashvili T, Stricker R, Reiser G. The mitochondria permeability transition pore complex in the brain with interacting proteins-promising targets for protection in neurodegenerative diseases. Biol Chem 2010; 391: 619-629.